These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 6205585

  • 1. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
    Nakano S, Kumada T, Sugiyama K, Watahiki H, Takeda I.
    Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
    [Abstract] [Full Text] [Related]

  • 2. Serum ferritin in hepatocellular carcinoma.
    Zhou XD, Stahlhut MW, Hann HL, London WT.
    Hepatogastroenterology; 1988 Feb; 35(1):1-4. PubMed ID: 2452122
    [Abstract] [Full Text] [Related]

  • 3. The clinical value of serum ferritin in hepatocellular carcinoma.
    Simonetti RG, Craxi A, Dardanonì G, Lanzarone F, Barbaria F, Cottone M, Pagliaro L.
    Hepatogastroenterology; 1985 Dec; 32(6):276-8. PubMed ID: 2419233
    [Abstract] [Full Text] [Related]

  • 4. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS, Hong SI, Park SY, Son Y, Lee YS, Chung YH, Yang SK, Suh DJ, Min YI.
    Anticancer Res; 1995 Dec; 15(6B):2777-80. PubMed ID: 8669863
    [Abstract] [Full Text] [Related]

  • 5. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y.
    Hepatogastroenterology; 1998 Dec; 45(23):1737-41. PubMed ID: 9840138
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
    Bruce MG, Bruden D, McMahon BJ, Christensen C, Homan C, Sullivan D, Deubner H, Williams J, Livingston SE, Gretch D.
    J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Mar; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.
    Anticancer Res; 2003 Mar; 23(2C):1747-53. PubMed ID: 12820452
    [Abstract] [Full Text] [Related]

  • 10. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis.
    Sato A, Kato Y, Nakata K, Nakao K, Daikoku M, Ishii N, Matsumoto T, Iseki K, Mazume H, Nagataki S.
    J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132
    [Abstract] [Full Text] [Related]

  • 11. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Oct; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 12. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y.
    Cancer; 2002 Aug 15; 95(4):824-34. PubMed ID: 12209727
    [Abstract] [Full Text] [Related]

  • 13. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W, Yao DF, Yuan YM, Fan JW, Lu XF, Li XH, Qiu LW, Zong L, Wu XH.
    Hepatobiliary Pancreat Dis Int; 2006 Nov 15; 5(4):538-44. PubMed ID: 17085339
    [Abstract] [Full Text] [Related]

  • 14. [Thyroxine-binding globulin--not a tumor marker of hepatocellular cancer].
    Sieg A, Schönpflug A, Seitz HK, Kommerell B.
    Z Gastroenterol; 1991 Mar 15; 29(3):101-4. PubMed ID: 1647573
    [Abstract] [Full Text] [Related]

  • 15. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
    Fujiyama S, Tsude K, Sakai M, Sato T.
    Hepatogastroenterology; 1990 Oct 15; 37(5):469-73. PubMed ID: 1701410
    [Abstract] [Full Text] [Related]

  • 16. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.
    Clin Oncol (R Coll Radiol); 2007 Apr 15; 19(3):197-203. PubMed ID: 17359907
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.
    Chin Med J (Engl); 2002 Jan 15; 115(1):42-5. PubMed ID: 11930656
    [Abstract] [Full Text] [Related]

  • 18. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T, Sakai T, Majima Y, Hirai K, Tanikawa K.
    Hepatogastroenterology; 1993 Aug 15; 40(4):347-51. PubMed ID: 7691701
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic utility of serum ferritin estimation in Nigerian patients with primary hepatocellular carcinoma.
    Ola SO, Akanji AO, Ayoola EA.
    Nutrition; 1995 Aug 15; 11(5 Suppl):532-4. PubMed ID: 8748215
    [Abstract] [Full Text] [Related]

  • 20. [A clinical study of complements as a marker of a hepatocellular carcinoma].
    Takezaki E, Murakami S, Nishibayashi H, Kagawa K, Ohmori H.
    Gan No Rinsho; 1990 Oct 15; 36(12):2119-22. PubMed ID: 1700167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.